Staphylococcus aureus encoding both TSST-1 and PVL in the UK
- Angela Kearns, Centre for Infections, Health Protection Agency, United Kingdom
|
Panton-Valentine Leukocidin: not as lethal as all that?
- Sharon Peacock, Mahidol-Oxford Tropical Medicine Research Unit, University of Oxford and Liverpool School of Tropical Medicine, Thailand
|
Panton-Valentine Leukocidin (PVL)-positive and -negative community-associated MRSA (CA-MRSA) USA400 sibling strains exhibit similar virulence characteristics in in vitro cell Cclture and animal models
- Kunyan Zhang, Centre for Antimicrobial Resistance, Calgary Health Region/Calgary Laboratory Services/University of Calgary, Canada
|
High Panton-Valentine leukocidin prevalence among community-associated methicillin-sensitive Staphylococcus aureus from Indonesia
- Ruud Deurenberg, University Hospital Maastricht, The Netherlands
|
Characteristics of Panton - Valentine leukocidin positive Staphylococcus aureus strains isolated in the Czech Republic
- Petr Petras, National Institute of Public Health, Czech Republic
- Roman Pantucek, Department of Genetics and Molecular Biology, Faculty of Science, Masaryk university, Kotlarska 2, 611 37 Brno, Czech Republic, Czech Republic
|
PVL-positivity among clinical and colonizing isolates of Staphylococcus aureus from children in south-west of Sweden
- Peter Nilsson, Clinical microbiology and infection control, County hospital, S-30185 Halmstad, Sweden., Sweden
|
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) in Finland: clinical infections, strain types and Panton-Valentine leukocidin genes
- Saara Salmenlinna, National Public Health Institute, Finland
|
Prevalence of Panton-Valentine Leukocidin (PVL) in Staphylococcus aureus isolates causing bacteraemia from a paediatric/obstetric hospital in South Australia 2004 - 2008
- Jan Bell, Women's and Children's Hospital, North Adelaide SA 5006, Australia
- John Turnidge, Women's and Children's Hospital, North Adelaide SA 5006, Australia
|